Milan, May 5, 2023.

Letizia Goretti holds a degree in Chemistry from the University of Perugia and began her career at Bristol-Myers Squibb in Italy before moving to The Janssen Pharmaceutical Companies where she held various roles

Alia Therapeutics, a Trento-based start-up specializing in innovative treatments for rare genetic diseases using next-generation gene-editing technology, has announced the appointment of Letizia Goretti as Chief Executive Officer (CEO) and Board Director, effective immediately. .Letizia, who joins Alia from Johnson

ContactContact name: Letizia GorettiContact description: Letizia GorettiContact telephone: 39 0461 283917